Humana Inc (HUM.N)
78.93USD
24 May 2013
$-0.91 (-1.14%)
$79.84
$79.42
$79.65
$78.27
269,652
501,351
$82.25
$59.92
HUM.N
About
Overall
| Beta: | 1.11 |
| Market Cap (Mil.): | $12,431.61 |
| Shares Outstanding (Mil.): | 157.50 |
| Dividend: | 0.27 |
| Yield (%): | 1.37 |
Financials
| HUM.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 8.84 | 145.58 | 34.30 |
| EPS (TTM): | 8.93 | -- | -- |
| ROI: | 11.17 | 0.27 | 18.43 |
| ROE: | 16.63 | 10.03 | 19.30 |
BRIEF-UK retailer House of Fraser 13 weeks to April 27 lfl sales up 4.8 pct
LONDON, May 22 - House of Fraser * UK retailer House of Fraser 13 weeks to April 27 like-for-like sales up 4.8
Humana doubles profit and raises 2013 view
- Humana Inc said its quarterly profit more than doubled as customers used medical services less than expected, so the company had to pay fewer claims. Humana also raised its profit forecast for the year.
UPDATE 3-Humana doubles profit and raises 2013 view
* Expects second-quarter profit of $2.40 to $2.50 per share
BRIEF-Humana shares up 3.9 percent in premarket trading
NEW YORK, May 1 - Humana Inc : * Shares up 3.9 percent in premarket trading after results
Humana doubles profit and raises 2013 view, but 2014 uncertain
- Humana Inc reported a much higher-than-expected first-quarter profit on Wednesday, but the health insurer expressed uncertainty about 2014, when lower government rates for private Medicare insurance take effect.
Humana profit rises, but company uncertain about 2014
May 1 - Humana Inc said Wednesday that first-quarter profit rose beyond its expectations, but the health insurer expressed uncertainty about its outlook for 2014, when lower U.S. government rates for private Medicare insurance go into effect.
Humana says started internal review after private medicare leak
- Health insurer Humana Inc said on Thursday that it has begun an internal review of the events around an announcement on April 1 of a government policy change related to private Medicare.
Humana says started internal review after private medicare leak
April 18 - Health insurer Humana Inc said on Thursday that it has begun an internal review of the events around an announcement on April 1 of a government policy change related to private Medicare.
U.S. justices decline to hear Glaxo appeal over Avandia
WASHINGTON - The U.S. Supreme Court on Monday declined to consider whether private insurers can sue giant drugmaker GlaxoSmithKline Plc over health costs incurred by its Avandia diabetes drug.
UPDATE 1-U.S. justices decline to hear Glaxo appeal over Avandia
WASHINGTON, April 15 - The U.S. Supreme Court on Monday declined to consider whether private insurers can sue giant drugmaker GlaxoSmithKline Plc over health costs incurred by its Avandia diabetes drug.
Competitors
| Price | Change | |
|---|---|---|
| UnitedHealth Group Inc. (UNH.N) | $62.06 | -0.30 |
| Axa SA (AXAF.PA) | €14.76 | +0.05 |
| WellPoint, Inc. (WLP.N) | $76.98 | -1.00 |
| ING Groep NV (ING.AS) | €7.00 | +0.03 |
| ING Groep NV (ING_p.AS) | -- | -- |
| Metlife Inc (MET.N) | $42.04 | -0.45 |
| Metlife Inc (MET_pa.N) | $25.72 | +0.16 |
| Metlife Inc (MLG.N) | $26.05 | +0.01 |
| AEGON N.V. (AEGN.AS) | €4.92 | -0.03 |
| Manulife Financial Corp. (MFC.TO) | $15.95 | -0.07 |
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Trading Report for (HUM). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Wright Reports
|
$426.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
